Product Classification

• Device: alpha-d-glucosidase (gaa) newborn screening test system
• Definition: For quantitative measurement of the activity of alpha-D-glucosidase (GAA) from newborn dried blood spot specimens.
• Physical State: Neonatal screening test
• Technical Method: Quantitative fluorimetric enzymatic activity assay.
• Target Area: Newborn dried blood spot specimens
• Regulation Medical Specialty: Clinical Chemistry
• Review Panel: Clinical Chemistry
• Product Code: PQU
• Premarket Review: Division of Chemistry and Toxicology Devices (DCTD); Division of Chemistry and Toxicology Devices (DCTD)
• Submission Type: 510(k)
• Regulation Number: 862.1488
• Device Class: 2
• Total Product Life Cycle (TPLC): TPLC Product Code Report
• GMP Exempt?: No
• Summary Malfunction Reporting: Ineligible
• Implanted Device?: No
• Life-Sustain/Support Device?: No

Third Party Review

• Eligible for 510(k) Third Party Review Program

Accredited Persons

• global quality and regulatory services
• regulatory technology services, llc